Endocannabinoids in cognition and dependence
- 28 February 2002
- journal article
- review article
- Published by Elsevier BV in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 66 (2-3), 269-285
- https://doi.org/10.1054/plef.2001.0351
Abstract
No abstract availableKeywords
This publication has 116 references indexed in Scilit:
- Effects of chronic Δ9-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-mazeNeuropharmacology, 2001
- D2 dopamine receptors enable Δ9 -tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentrationBritish Journal of Pharmacology, 2000
- Brain Regional Distribution of Endocannabinoids: Implications for Their Biosynthesis and Biological FunctionBiochemical and Biophysical Research Communications, 1999
- Δ9-Tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidanceLife Sciences, 1998
- Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and ratFEBS Letters, 1996
- The endogenous cannabinoid receptor agonist anandamide impairs memory in ratsBehavioural Pharmacology, 1996
- Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brainLife Sciences, 1996
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorFEBS Letters, 1994
- Acute effects of marijuana smoke on complex operant behavior in rhesus monkeysLife Sciences, 1989
- CLONIDINE BLOCKS ACUTE OPIATE-WITHDRAWAL SYMPTOMSThe Lancet, 1978